CoChat

Epigenetic Switch–Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer

Deblois, Geneviève, Tonekaboni, Seyed Ali Madani, Grillo, Giacomo, Martinez, Constanza, Kao, Yunchi Ingrid, Tai, Felicia, Ettayebi, Ilias, Fortier, Anne-Marie, Savage, Paul, Fedor, Alexandra N., Liu, Xiaojing, Guilhamon, Paul, Lima-Fernandes, Evelyne, Murison, Alex, Kuasne, Hellen, Ba-alawi, Wail, Cescon, David W., Arrowsmith, Cheryl H., De Carvalho, Daniel D., Haibe-Kains, Benjamin, Locasale, Jason W., Park, Morag, Lupien, Mathieu · 2020 · Cancer Discovery
Cited by 147

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Tumor progression upon treatment arises from preexisting resistant cancer cells and/or adaptation of persister cancer cells committing to an expansion phase. Here, we show that evasion from viral mimicry response allows the growth of taxane-resistant triple-negative breast cancer (TNBC). This is enabled by an epigenetic state adapted to taxane-induced metabolic stress, where DNA hypomethylation over loci enriched in transposable elements (TE) is compensated by large chromatin domains of H3K27me3 to warrant TE repression. This epigenetic state creates a vulnerability to epigenetic therapy against EZH2, the H3K27me3 methyltransferase, which alleviates TE repression in taxane-resistant TNBC, leading to double-stranded RNA production and growth inhibition through viral mimicry response. Collectively, our results illustrate how epigenetic states over TEs promote cancer progression under treatment and can inform about vulnerabilities to epigenetic therapy. Significance: Drug-resistant cancer cells represent a major barrier to remission for patients with cancer. Here we show that drug-induced metabolic perturbation and epigenetic states enable evasion from the viral mimicry response induced by chemotherapy in TNBC. These epigenetic states define a vulnerability to epigenetic therapy using EZH2 inhibitors in taxane-resistant TNBC. See related commentary by Janin and Esteller, p. 1258. This article is highlighted in the In This Issue feature, p. 1241

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-19-1493

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 147

Metadata

Authors
Deblois, G., Tonekaboni, S. A. M., Grillo, G., Martinez, C., Kao, Y. I., Tai, F., Ettayebi, I., Fortier, A.-M., Savage, P., Fedor, A. N., Liu, X., Guilhamon, P., Lima-Fernandes, E., Murison, A., Kuasne, H., Ba-alawi, W., Cescon, D. W., Arrowsmith, C. H., De Carvalho, D. D., Haibe-Kains, B., Locasale, J. W., Park, M., & Lupien, M.
Venue
Cancer Discovery
Published
2020-09-01
Volume
10
Issue
9
Pages
1312-1329
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3035191018
Cited by
147
References
13
FWCI
5.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetic Switch–Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer. https://app.cochat.ai/papers/10.1158/2159-8290.cd-19-1493
The paper
Deblois, G., Tonekaboni, S. A. M., Grillo, G., Martinez, C., Kao, Y. I., Tai, F., Ettayebi, I., Fortier, A.-M., Savage, P., Fedor, A. N., Liu, X., Guilhamon, P., Lima-Fernandes, E., Murison, A., Kuasne, H., Ba-alawi, W., Cescon, D. W., Arrowsmith, C. H., De Carvalho, D. D., . . . Lupien, M. (2020). Epigenetic Switch–Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-19-1493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.